Tag: Mallya
Diabetes: Biocorp has obtained authorization to market its Mallya device in the United States – 07/12/2022 at 17:22
(AOF) – Biocorp, a French company specializing in the development and manufacture of medical devices and injectable drug delivery systems, announces today that it has received 510(K) clearance from the…
BIOCORP and NOVO NORDISK strengthen their partnership with a new agreement on the Mallya® connected device – 2022-10-26 at 07:30
Issoire, October 26, 2022, 7:30 a.m. CEST – BIOCORP (FR0012788065 – ALCOR / PEA‐PME eligible), a French company specializing in the development and manufacture of medical devices and injectable drug…